SPECIAL NOTICE
B -- Next Generation Sequencing Reagents
- Notice Date
- 12/17/2012
- Notice Type
- Special Notice
- NAICS
- 325411
— Medicinal and Botanical Manufacturing
- Contracting Office
- Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
- ZIP Code
- 30341-4146
- Solicitation Number
- 2013-N-14975
- Archive Date
- 1/18/2013
- Point of Contact
- Sharon R Cunningham, Phone: 770-488-2871, Julio E Lopez, Phone: 770-488-2892
- E-Mail Address
-
cux0@cdc.gov, ftg4@cdc.gov
(cux0@cdc.gov, ftg4@cdc.gov)
- Small Business Set-Aside
- N/A
- Description
- The Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, intends to award a sole source firm fixed price Blanket Purchase Agreement to Illumina Inc,. in San Diego, California. The purpose of this procurement is to establish a Blanket Purchase Agreement in order to purchase of the following reagents kits to be licensed for use on the Illumina Genome Analyzer IIx system: TruSeq DNA Sample Prep Kit, set a or b v2 or higher; Truseq RNA sample prep kit v2 (set a and b); Truseq small RNA sample prep kit (set a,b,c,d); Nextera DNA sample prep (24 samples); Nextera DNA sample prep (96 samples); Nextera index kit (24 indices, 96 samples); TruSeq Dual Index Seq primer kit, single and paired end; Truseq single read Cluster Kit cBOT, v2 or higher, for Illumina Genome Analyzer GAIIx; Truseq paired end Cluster Kit cBOT, v2 or higher, for Illumina Genome Analyzer GAIIx; Truseq dual index sequencing primer kit, paired end; Truseq dual index sequencing primer kit, single read; Truseq SBS sequencing kits for Illumina Genome Analyzer GAIIx, v5 or newer; and Multiplexing Sample Prep Oligo Kit. The resultant contract will be for a base period of 12 months and four option periods of 12 months each. The Government believes that the items to be procured are proprietary and are only available from Illumina Inc.The statutory authority for this sole source acquisition is 10 U.S.C 2304(c)(1) in accordance with FAR Part 6.302-1- only one responsible source and no other supplies or services will satisfy the agency requirement. The NAICS code for this procurement is 325411, Medicinal and Botanical Manufacturing. All responsible sources that believe they can meet these requirements may submit their capability statements via email by 2:00 P.M., EST on January 3, 2013, to the Contracting Office at the following e-mail address: scunningham1@cdc.gov. Any questions must be submitted to the Contracting Office. in writing, to the email address listed above. Telephone calls will not be allowed. A determination by the Government not to compete this proposed action will be based on responses to this notice and are solely within the discretion of the Contracting Officer. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/2013-N-14975/listing.html)
- Place of Performance
- Address: Contractor Facility, United States
- Record
- SN02950167-W 20121219/121217234222-037f4c170360004ad39feda109df5f21 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |